Over the past year, ELTP insiders bought $8,610 of stock (30K shares) on the open market and sold none.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Nasrat A Hakim | Ceo, President | 216,649,250 | 0 | 216,649,250 | 90.7% | 02 Apr, 2024 |
| 2 | Douglas Plassche | Evp Operations | 9,500,000 | 0 | 9,500,000 | 4.0% | 13 Jan, 2026 |
| 3 | Pharmaceuticals Inc /Nv/ Elite | Evp Operations | 4,300,000 | 0 | 4,300,000 | 1.8% | 26 Aug, 2025 |
| 4 | Barry H Dash | Director | 3,265,555 | 0 | 3,265,555 | 1.4% | 10 Sep, 2026 |
| 5 | Jeffrey A Whitnell | Director | 3,187,020 | 0 | 3,187,020 | 1.3% | 27 Nov, 2023 |
| 6 | Davis S Caskey | Director | 2,049,436 | 0 | 2,049,436 | 0.9% | 27 Nov, 2023 |
| 7 | Kirko Kirkov | Chief Commercial Officer | 16,366 | 0 | 16,366 | 0.0% | 25 Jul, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 19 Aug, 2026 | Barry H Dash | Director | Acquired P | 30,000 | $0.29 | $8.61K | 3,265,555 | Direct |
| 09 Jan, 2026 | Douglas Plassche | Evp Operations | Acquired M | 2,500,000 | $0.03 | $75.00K | 6,000,000 | Direct |
| 09 Jan, 2026 | Douglas Plassche | Evp Operations | Disposed M | 2,500,000 | $0.00 | $0 | 0 | Direct |
| 02 Oct, 2025 | Douglas Plassche | Evp Operations | Disposed S | 800,000 | $0.62 | $499.20K | 3,500,000 | Direct |
| 22 Aug, 2025 | Pharmaceuticals Inc /Nv/ Elite | Evp Operations | Disposed S | 500,000 | $0.52 | $262.15K | 1,800,000 | Direct |
| 25 Aug, 2025 | Pharmaceuticals Inc /Nv/ Elite | Evp Operations | Acquired M | 2,500,000 | $0.03 | $75.00K | 4,300,000 | Direct |
| 25 Aug, 2025 | Pharmaceuticals Inc /Nv/ Elite | Evp Operations | Disposed M | 2,500,000 | $0.00 | $0 | 2,500,000 | Direct |
| 10 Jul, 2025 | Kirko Kirkov | Chief Commercial Officer | Acquired P | 16,366 | $0.59 | $9.64K | 16,366 | Direct |
| 08 Jul, 2025 | Douglas Plassche | Evp Operations | Disposed S | 200,000 | $0.58 | $115.80K | 2,300,000 | Direct |
| 03 Jul, 2025 | Douglas Plassche | Evp Operations | Acquired M | 2,500,000 | $0.03 | $75.00K | 2,500,000 | Direct |
| 03 Jul, 2025 | Douglas Plassche | Evp Operations | Disposed M | 2,500,000 | $0.00 | $0 | 5,000,000 | Direct |
| 23 Oct, 2024 | Douglas Plassche | Svp Of Operations | Disposed S | 800,000 | $0.49 | $392.00K | 333,932 | Direct |
| 24 Oct, 2024 | Douglas Plassche | Svp Of Operations | Disposed S | 333,932 | $0.51 | $170.31K | 0 | Direct |
| 29 Mar, 2024 | Nasrat A Hakim | Ceo, President | Acquired A | 49,534,368 | $0.00 | $0 | 216,649,250 | Direct |
| 29 Dec, 2023 | Nasrat A Hakim | Ceo, President | Acquired A | 2,223,147 | $0.07 | $153.40K | 2,223,147 | Indirect |
| 22 Nov, 2023 | Jeffrey A Whitnell | Director | Acquired A | 547,657 | $0.04 | $19.99K | 3,187,020 | Direct |
| 22 Nov, 2023 | Davis S Caskey | Director | Acquired A | 547,657 | $0.04 | $19.99K | 2,049,436 | Direct |
| 22 Nov, 2023 | Barry H Dash | Director | Acquired A | 547,657 | $0.04 | $19.99K | 3,235,555 | Direct |
| 06 Sep, 2022 | Kirko Kirkov | Chief Commercial Officer | Acquired A | 3,000,000 | $0.04 | $105.00K | 3,000,000 | Direct |
| 28 Aug, 2022 | Jeffrey A Whitnell | Director | Acquired A | 459,536 | $0.04 | $19.99K | 2,639,363 | Direct |